Literature DB >> 8248212

TAP1 alleles in insulin-dependent diabetes mellitus: a newly defined centromeric boundary of disease susceptibility.

D G Jackson1, J D Capra.   

Abstract

It has been previously demonstrated that individuals with certain DR alleles have an increased relative risk of developing insulin-dependent diabetes mellitus (IDDM). The disease association is even stronger with certain DQ alleles but there is little association with DP providing a boundary of disease association to the 430 kb between DQ and DP. The recently described TAP (transporter associated with antigen processing) genes have been mapped approximately midway between DP and DQ. Therefore, it was of interest to determine if any TAP alleles were associated with IDDM. In addition to the alleles of TAP1 that have been described, others were identified during this study. Diabetics and normal controls were screened for TAP1 using single-stranded conformational polymorphism and relative risk was determined. In the same population group we have studied extensively in the past, we found a higher association of a TAP1 allele with IDDM than with any single HLA-DP allele but the risk was lower than with HLA-DQB1*0302. These data provide new limits for IDDM susceptibility to the 190-kb interval between TAP1 and HLA-DQB1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248212      PMCID: PMC47925          DOI: 10.1073/pnas.90.23.11079

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Mapping genes in the mouse using single-strand conformation polymorphism analysis of recombinant inbred strains and interspecific crosses.

Authors:  D R Beier; H Dushkin; D J Sussman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

3.  Ham-2 corrects the class I antigen-processing defect in RMA-S cells.

Authors:  M Attaya; S Jameson; C K Martinez; E Hermel; C Aldrich; J Forman; K F Lindahl; M J Bevan; J J Monaco
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

4.  Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system.

Authors:  J G Bodmer; S G Marsh; E D Albert; W F Bodmer; B Dupont; H A Erlich; B Mach; W R Mayr; P Parham; T Sasazuki
Journal:  Tissue Antigens       Date:  1992-04

5.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

6.  Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism.

Authors:  M Carrington; T Miller; M White; B Gerrard; C Stewart; M Dean; D Mann
Journal:  Hum Immunol       Date:  1992-03       Impact factor: 2.850

7.  Linkage of faulty major histocompatibility complex class I to autoimmune diabetes.

Authors:  D Faustman; X P Li; H Y Lin; Y E Fu; G Eisenbarth; J Avruch; J Guo
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

8.  A particular subset of HLA-DR4 accounts for all or most of the DR4 association in type I diabetes.

Authors:  M J Sheehy; J R Rowe; M J MacDonald
Journal:  Diabetes       Date:  1985-09       Impact factor: 9.461

9.  Analysis of HLA genotypes and susceptibility to insulin-dependent diabetes mellitus: HLA-DQ alpha complements HLA-DQ beta.

Authors:  J M Baisch; M E O'Brien; M L Hoover; J D Capra
Journal:  Scand J Immunol       Date:  1992-08       Impact factor: 3.487

10.  Genetic modulation of antigen presentation by HLA-B27 molecules.

Authors:  L Pazmany; S Rowland-Jones; S Huet; A Hill; J Sutton; R Murray; J Brooks; A McMichael
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 2.  Superantigens in insulin-dependent diabetes mellitus.

Authors:  P Luppi; M Trucco
Journal:  Springer Semin Immunopathol       Date:  1996

3.  New polymorphisms within the human TAP1 and TAP2 coding regions.

Authors:  H Moins-Teisserenc; V Bobrynina; P Loiseau; D Charron
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  Transporters from H-2b, H-2d, H-2s, H-2k, and H-2g7 (NOD/Lt) haplotype translocate similar sets of peptides.

Authors:  T N Schumacher; D V Kantesaria; D V Serreze; D C Roopenian; H L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  BRD2 and TAP-1 genes and juvenile myoclonic epilepsy.

Authors:  Samia Layouni; Catherine Buresi; Pierre Thomas; Alain Malafosse; Mohamed Dogui
Journal:  Neurol Sci       Date:  2009-12-02       Impact factor: 3.307

6.  Genetic susceptibility to type 1 diabetes in the intracellular pathway of antigen processing - a subject review and cross-study comparison.

Authors:  Charles Sia; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2005-05-10

7.  Reproductive failure and the major histocompatibility complex.

Authors:  K Jin; H N Ho; T P Speed; T J Gill
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

8.  HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus.

Authors:  L Esposito; V Lampasona; E Bosi; F Poli; M Ferrari; E Bonifacio
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

9.  TAP1 I333V gene polymorphism and type 1 diabetes mellitus: a meta-analysis of 2248 cases.

Authors:  Yan-Yan Li; Wei Gao; Si-Si Pang; Xiao-Yan Min; Zhi-Jian Yang; Hui Wang; Xin-Zheng Lu; Lian-Sheng Wang; Xiang-Ming Wang; Yun Qian; Chuan-Wei Zhou; Jun Wu; Ai-Ling Chen
Journal:  J Cell Mol Med       Date:  2014-03-21       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.